Sex Differences in E-Cigarette Perception (NCT07398976)

🧪 Interventions in This Study

• Nicotine Level 1 (0mg/ml) (OTHER)
• Nicotine Level 2 (36mg/ml) (OTHER)
• Nicotine Level 3 (59mg/ml) (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Yale School of Medicine — New Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (203) 974-7607

Email: danielle.davis@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Nicotine Dependence

• Targeting Orexin to Treat Nicotine Dependence — Belmont, Massachusetts
• Electronic Cigarettes and Reactivity to Smoking Cues — Belmont, Massachusetts
• NeuroControl of Nicotine Dependence — Columbia, Missouri
• Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use — Los Angeles, California
• Orexin s Role in the Neurobiology of Substance Use Disorder — Baltimore, Maryland

Explore by condition: All Nicotine Dependence clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.